This stands in contrast to well-characterized neurodegenerative disorders, such as AD or frontotemporal dementia, where elevated NfL levels in blood or cerebrospinal fluid consistently reflect progressive neuronal loss [16,17,18]. The gene discussed is NEFL; the disease is Alzheimer disease.